Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050646
Company: GLAXOSMITHKLINE

Products on NDA 50646

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CEPTAZ	CEFTAZIDIME	500MG/VIAL	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPTAZ	CEFTAZIDIME	1GM/VIAL	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPTAZ	CEFTAZIDIME	2GM/VIAL	INJECTABLE;INJECTION	Discontinued	None	No	No
CEPTAZ	CEFTAZIDIME	10GM/VIAL	INJECTABLE;INJECTION	Discontinued	None	No	No

Labels for NDA 050646

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/29/2002	SUPPL-14	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/050646s014lbl.pdf